We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.6B
AUM Growth
-$325M
Cap. Flow
-$723M
Cap. Flow %
-4.97%
Top 10 Hldgs %
7.37%
Holding
1,080
New
68
Increased
314
Reduced
422
Closed
79

Top Sells

Rank Stock Value
1
IMXI icon
International Money Express
IMXI
+$42M
2
OLN icon
Olin
OLN
+$40.2M
3
BC icon
Brunswick
BC
+$36.7M
4
AA icon
Alcoa
AA
+$33.9M
5
USCR
U S Concrete, Inc.
USCR
+$31.9M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 20.04%
3 Financials 15.03%
4 Consumer Discretionary 13.3%
5 Healthcare 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCPL
701
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$2.88M 0.02%
169,937
-199,015
-54% -$3.43M
KTOS icon
702
Kratos Defense & Security Solutions
KTOS
$8.23B
$2.88M 0.02%
101,000
ENVX icon
703
Enovix
ENVX
$803M
$2.87M 0.02%
142,857
+57,143
+67% +$775K
VNDA icon
704
Vanda Pharmaceuticals
VNDA
$304M
$2.87M 0.02%
133,411
-3,347
-2% -$59.9K
BWL.A
705
DELISTED
Bowl America Incorporated
BWL.A
$2.86M 0.02%
325,000
-104,077
-24% -$1.02M
GWW icon
706
W.W. Grainger
GWW
$64.2B
$2.85M 0.02%
6,500
CAC icon
707
Camden National
CAC
$988M
$2.84M 0.02%
59,470
+4,400
+8% +$209K
ENS icon
708
EnerSys
ENS
$6.43B
$2.83M 0.02%
29,000
DGICA icon
709
Donegal Group Class A
DGICA
$715M
$2.82M 0.02%
193,516
+118,341
+157% +$1.81M
ATLO icon
710
AMES National
ATLO
$271M
$2.82M 0.02%
115,030
-4,300
-4% -$109K
UNTY icon
711
Unity Bancorp
UNTY
$590M
$2.81M 0.02%
127,325
+4,818
+4% +$108K
ENTG icon
712
Entegris
ENTG
$16.3B
$2.79M 0.02%
22,700
-30,400
-57% -$3.49M
MSGM icon
713
Motorsport Games
MSGM
$17.9M
$2.79M 0.02%
19,909
+7,109
+56% +$1.26M
SGA icon
714
Saga Communications
SGA
$54.9M
$2.78M 0.02%
128,478
-38,044
-23% -$838K
LARK icon
715
Landmark Bancorp
LARK
$195M
$2.77M 0.02%
131,075
+46,838
+56% +$955K
MEDP icon
716
Medpace
MEDP
$16.3B
$2.75M 0.02%
15,568
SDGR icon
717
Schrodinger
SDGR
$1.13B
$2.75M 0.02%
36,350
-26,000
-42% -$1.88M
FLWS icon
718
1-800-Flowers.com
FLWS
$252M
$2.74M 0.02%
+85,840
New +$2.68M
UFAB
719
DELISTED
Unique Fabricating, Inc.
UFAB
$2.73M 0.02%
738,828
-27,344
-4% -$114K
REED
720
DELISTED
Reeds, Inc. Common Stock
REED
$2.71M 0.02%
53,158
-29,466
-36% -$1.51M
UTMD icon
721
Utah Medical Products
UTMD
$226M
$2.71M 0.02%
31,840
-5
-0% -$433
ARCT icon
722
Arcturus Therapeutics
ARCT
$165M
$2.7M 0.02%
79,836
IMMR icon
723
Immersion
IMMR
$243M
$2.67M 0.02%
+305,000
New +$2.61M
FISI icon
724
Financial Institutions
FISI
$812M
$2.67M 0.02%
88,918
+1,297
+1% +$40.5K
IBEX icon
725
IBEX
IBEX
$489M
$2.66M 0.02%
136,320
-8,696
-6% -$188K

Similar funds

Royce & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Royce & Associates held 1,080 positions worth $14.6B, down 2.2% from $14.9B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Royce & Associates withdrew a net $723M in Q2 2021, closing 79 positions and reducing 422 holdings. Its most notable exit was Olin, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Organon & Co worth $16.5M.

  • Royce & Associates's largest Q2 2021 buy was Organon & Co: 546,803 shares worth $16.5M.
  • Royce & Associates added most to Vontier in Q2 2021, an estimated $50.7M increase.
  • Royce & Associates's biggest Q2 2021 reduction was International Money Express, cutting an estimated $42M.
  • Royce & Associates fully exited Olin in Q2 2021, selling an estimated $40.2M.
  • Royce & Associates's ten largest holdings make up 7.4% of its $14.6B portfolio in Q2 2021.
  • Royce & Associates opened 68 new positions and closed 79 in Q2 2021.
  • Royce & Associates's portfolio value fell 2.2% quarter-over-quarter to $14.6B.

Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.